SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: technetx who wrote (141)8/17/1998 8:11:00 AM
From: Thomas Kirwin  Read Replies (1) of 422
 
ABS2000 Sales Possibility - University HealthSystem Consortium

Technetx,

An old Immucor news item contained in The Week in Business section of Atlanta Business Chronicle dated July 15, 1996 reported.....

"Immucor has signed a three-year contract to supply its current products and the ABS2000 after approval to the University HealthSystem Consortium, a buying group of 66 academic medical centers and 55 affiliated hospitals. Immucor considers the deal an endorsement of its blood bank instrument under review by the FDA, Still said. The company also has won a three-year contract from one of the largest U.S.-based private laboratory chains."

amcity.com

Wow, if Immucor closes a deal with the University HealthSystem Consortium to place one ABS2000 unit at each site the total number of placements could be as high as 121. The revenue generated from this deal alone could be in excess of $9 million with an annual reagent trail of $3.6 million.

Lets go Immucor!

Regards,

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext